Kongying Lin

843 total citations
48 papers, 466 citations indexed

About

Kongying Lin is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Kongying Lin has authored 48 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hepatology, 18 papers in Surgery and 17 papers in Epidemiology. Recurrent topics in Kongying Lin's work include Hepatocellular Carcinoma Treatment and Prognosis (35 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers) and Liver Disease Diagnosis and Treatment (13 papers). Kongying Lin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (35 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers) and Liver Disease Diagnosis and Treatment (13 papers). Kongying Lin collaborates with scholars based in China, Hong Kong and United States. Kongying Lin's co-authors include Weiping Zhou, Jingfeng Liu, Shengxian Yuan, Yongyi Zeng, Fu Yang, Chuanchuan Zhou, Ji‐hang Yuan, Fang Wang, Jianxing Zeng and Jinzhao Ma and has published in prestigious journals such as Hepatology, Journal of Hepatology and Frontiers in Immunology.

In The Last Decade

Kongying Lin

42 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kongying Lin China	12	206	186	159	123	96	48	466
Yadi Liao China	16	204 1.0×	185 1.0×	250 1.6×	137 1.1×	126 1.3×	21	582
Erlei Zhang China	16	293 1.4×	153 0.8×	166 1.0×	200 1.6×	104 1.1×	61	562
Massimo De Giorgio Italy	7	280 1.4×	113 0.6×	111 0.7×	206 1.7×	105 1.1×	15	451
Wan Ling Tan Singapore	8	144 0.7×	92 0.5×	79 0.5×	85 0.7×	149 1.6×	22	407
Masaki Tateishi Japan	12	173 0.8×	67 0.4×	101 0.6×	88 0.7×	155 1.6×	31	416
Funan Qiu China	12	183 0.9×	241 1.3×	239 1.5×	91 0.7×	126 1.3×	32	593
Ami Yu South Korea	11	108 0.5×	101 0.5×	98 0.6×	76 0.6×	161 1.7×	22	430
Chong‐De Lu China	9	155 0.8×	141 0.8×	131 0.8×	74 0.6×	101 1.1×	16	376
Yong‐Fa Zhang China	17	397 1.9×	174 0.9×	158 1.0×	194 1.6×	160 1.7×	32	654

Countries citing papers authored by Kongying Lin

Since Specialization

Citations

This map shows the geographic impact of Kongying Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kongying Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kongying Lin more than expected).

Fields of papers citing papers by Kongying Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kongying Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kongying Lin. The network helps show where Kongying Lin may publish in the future.

Co-authorship network of co-authors of Kongying Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Kongying Lin. A scholar is included among the top collaborators of Kongying Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kongying Lin. Kongying Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yao, Lan‐Qing, Lei Cai, Kongying Lin, et al.. (2025). Impact of compliance to postoperative regular follow-up on long-term prognosis after curative resection for hepatocellular carcinoma: A multicenter analysis. Hepatobiliary & pancreatic diseases international. 24(3). 261–268. 1 indexed citations

Huang, Qizhen, Xiaohong Zhong, Shaoxing Chen, et al.. (2025). Efficacy and safety of radiotherapy versus transarterial chemoembolization in combination with lenvatinib and camrelizumab for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: a multicenter study. Hepatology International. 19(4). 877–887. 2 indexed citations

Wu, Mengmeng, et al.. (2025). Time to recurrence and BCLC stage at recurrence as critical variables in guiding treatment decisions for early-recurrent hepatocellular carcinoma after liver resection. Frontiers in Oncology. 15. 1672696–1672696.

Chi, Qingguo, Shuangjia Wang, Yue Liu, et al.. (2025). Lenvatinib combined with anti-PD-1 antibodies plus locoregional treatment for initial unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter real-world study. BMC Cancer. 25(1). 1162–1162.

Tang, Shichuan, Cong Luo, Jun Fu, et al.. (2024). Tumor burden score and alpha-fetoprotein level predict prognosis of patients with unresectable hepatocellular carcinoma treated with tyrosine kinase inhibitor and anti-PD-1 antibody. PubMed. 3(3). 100109–100109.

Lin, Kongying, Bing Zhang, Mingqiang Liu, et al.. (2023). Association of hepatitis B virus DNA levels with efficacy and safety outcomes in patients with hepatitis B virus-associated advanced hepatocellular carcinoma receiving tyrosine kinase inhibitor plus anti-PD-1 antibody: a multicenter propensity-matched study. International Immunopharmacology. 125(Pt A). 111098–111098. 3 indexed citations

Huang, Qizhen, Kongying Lin, Hongbin Ji, et al.. (2023). Prognosis value of microscopic bile duct invasion in hepatocellular carcinoma: A multicenter study. Cancer Medicine. 12(22). 20821–20829. 2 indexed citations

Liu, Lei, Kongying Lin, Xiaojie Gan, et al.. (2023). Perioperative and long-term survival outcomes of laparoscopic versus open hepatectomy for BCLC stage A large hepatocellular carcinoma patients in difficult segments: A two-centre, propensity score matching analysis. Frontiers in Oncology. 13. 1095357–1095357. 2 indexed citations

Lin, Kongying, Jinhong Chen, Kui Wang, et al.. (2023). Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients. Hepatology International. 17(6). 1477–1489. 6 indexed citations

10.

Lin, Kongying, et al.. (2023). A novel preoperative inflammation score system established for postoperative prognosis predicting of intrahepatic cholangiocarcinoma. BMC Cancer. 23(1). 188–188. 3 indexed citations

11.

Zhang, Yalan, et al.. (2022). Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers. Frontiers in Pharmacology. 13. 871262–871262. 3 indexed citations

12.

Yang, Yun, Zheng Dang, Peng Lü, et al.. (2021). Impact of pathological response after preoperative transcatheter arterial chemoembolization (TACE) on incidences of microvascular invasion and early tumor recurrence in hepatocellular carcinoma: a multicenter propensity score matching analysis. HepatoBiliary Surgery and Nutrition. 11(3). 386–399. 17 indexed citations

13.

Huang, Qizhen, Yufeng Chen, Kongying Lin, et al.. (2021). Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter Study. Frontiers in Oncology. 11. 673285–673285. 5 indexed citations

14.

Lin, Kongying, Qizhen Huang, Lei Wang, et al.. (2021). Pre- and Postoperative Models for Prediction of Recurrence in Non-B, Non-C Hepatocellular Carcinoma. Frontiers in Oncology. 11. 612588–612588. 2 indexed citations

15.

Lin, Kongying, Qizhen Huang, Guoxu Fang, et al.. (2021). An MR-based radiomics model for differentiation between hepatocellular carcinoma and focal nodular hyperplasia in non-cirrhotic liver. World Journal of Surgical Oncology. 19(1). 181–181. 16 indexed citations

16.

Wang, Lei, Chunhong Xiao, Ren Wang, et al.. (2020). The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Intermediate Hepatocellular Carcinoma After Radical Hepatectomy: a Propensity Score-Matching Study. Journal of Gastrointestinal Surgery. 25(5). 1172–1183. 7 indexed citations

17.

Chen, Qinjunjie, Kongying Lin, Hongzhi Liu, et al.. (2020). Distinct Impacts of Pre-Operative Antiviral Treatment on Post-Operative Outcomes of HBV-related Hepatocellular Carcinoma: A Landmark Analysis. Journal of Cancer. 12(1). 170–180. 4 indexed citations

18.

Wang, Lei, Qiao Ke, Kongying Lin, et al.. (2020). <p>Not All Hepatocellular Carcinoma Patients with Microvascular Invasion After R0 Resection Could Be Benefited from Prophylactic Transarterial Chemoembolization: A Propensity Score Matching Study</p>. Cancer Management and Research. Volume 12. 3815–3825. 13 indexed citations

19.

Tao, Qi-fei, Zhiheng Wang, Kongying Lin, et al.. (2019). Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm – A retrospective cohort study. The American Journal of Surgery. 219(4). 717–725. 9 indexed citations

20.

Xu, Qingguo, Shengxian Yuan, Qi-fei Tao, et al.. (2019). A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma. Journal of Hepatology. 70(5). 904–917. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact